Literature DB >> 23394562

N-glycosylation of plant-produced recombinant proteins.

Dirk Bosch1, Alexandra Castilho, Andreas Loos, Arjen Schots, Herta Steinkellner.   

Abstract

Plants are gaining increasingly acceptance as a production platform for recombinant proteins. One reason for this is their ability to carry out posttranslational protein modifications in a similar if not identical way as mammalian cells. The capability of plants to carry out human-like complex glycosylation is well known. Moreover, the targeted manipulation of the plant N-glycosylation pathway allows the production of proteins carrying largely homogeneous, human-type oligosaccharides. These outstanding results have placed plants in a favourable position compared to other eukaryotic expression systems. This review provides a comprehensive summary of the N-glycosylation of plant-produced recombinant proteins, the possible impact of plant-specific N-glycans on the human immune system, and recent advances in engineering the plant N-glycosylation pathway towards the synthesis of (complex) human-type glycan structures, highlighting challenges and achievements in the application of these powerful technologies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23394562     DOI: 10.2174/1381612811319310006

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  51 in total

1.  Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human β1,4-galactosyltransferase and human CTLA4Ig.

Authors:  Seung Hoon Kang; Hahn Sun Jung; Song Jae Lee; Cheon Ik Park; Sang Min Lim; Heajin Park; Byung Sun Kim; Kwang Heum Na; Gyeong Jin Han; Jae Woo Bae; Hyun Joo Park; Keuk Chan Bang; Byung Tae Park; Hye Seong Hwang; In-Soo Jung; Jae Il Kim; Doo Byung Oh; Dong Il Kim; Hirokazu Yagi; Koichi Kato; Dae Kyong Kim; Ha Hyung Kim
Journal:  Glycoconj J       Date:  2015-05-14       Impact factor: 2.916

2.  Glyco-Engineering of Plant-Based Expression Systems.

Authors:  Rainer Fischer; Tanja Holland; Markus Sack; Stefan Schillberg; Eva Stoger; Richard M Twyman; Johannes F Buyel
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  Plant specific N-glycans do not have proven adverse effects in humans.

Authors:  Yoseph Shaaltiel; Yoram Tekoah
Journal:  Nat Biotechnol       Date:  2016-07-12       Impact factor: 54.908

4.  On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.

Authors:  Jianfeng Xu; Ningning Zhang
Journal:  Pharm Bioprocess       Date:  2014-12-01

5.  Expression, purification, and phylogenetic analysis of MDIS1-INTERACTING RECEPTOR-LIKE KINASE1 (MIK1).

Authors:  Krittin Trihemasava; Sayan Chakraborty; Kevin Blackburn; Guozhou Xu
Journal:  Protein J       Date:  2020-10-26       Impact factor: 2.371

6.  Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.

Authors:  Stephen Tottey; Yoko Shoji; R Mark Jones; Jessica A Chichester; Brian J Green; Konstantin Musiychuk; Huaxin Si; Slobodanka D Manceva; Amy Rhee; Moneim Shamloul; Joey Norikane; Rosane C Guimarães; Elena Caride; Andrea N M R Silva; Marisol Simões; Patricia C C Neves; Renato Marchevsky; Marcos S Freire; Stephen J Streatfield; Vidadi Yusibov
Journal:  Am J Trop Med Hyg       Date:  2017-11-30       Impact factor: 2.345

7.  N-Glycosylation of an IgG antibody secreted by Nicotiana tabacum BY-2 cells can be modulated through co-expression of human β-1,4-galactosyltransferase.

Authors:  Catherine Navarre; Nicolas Smargiasso; Laurent Duvivier; Joseph Nader; Johann Far; Edwin De Pauw; Marc Boutry
Journal:  Transgenic Res       Date:  2017-03-22       Impact factor: 2.788

8.  Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.

Authors:  Stefan Michelfelder; Juliana Parsons; Lennard L Bohlender; Sebastian N W Hoernstein; Holger Niederkrüger; Andreas Busch; Nicola Krieghoff; Jonas Koch; Benjamin Fode; Andreas Schaaf; Thomas Frischmuth; Martin Pohl; Peter F Zipfel; Ralf Reski; Eva L Decker; Karsten Häffner
Journal:  J Am Soc Nephrol       Date:  2016-12-08       Impact factor: 10.121

9.  Development of a single-replicon miniBYV vector for co-expression of heterologous proteins.

Authors:  Alex Prokhnevsky; Tarlan Mamedov; Brett Leffet; Rahila Rahimova; Ananya Ghosh; Vadim Mett; Vidadi Yusibov
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

10.  Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants.

Authors:  Huafang Lai; Junyun He; Jonathan Hurtado; Jake Stahnke; Anja Fuchs; Erin Mehlhop; Sergey Gorlatov; Andreas Loos; Michael S Diamond; Qiang Chen
Journal:  Plant Biotechnol J       Date:  2014-06-29       Impact factor: 9.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.